Work

Phase I study of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps2619

Authors: David W. Cescon, Aaron Richard Hansen, Albiruni Ryan Abdul Razak, Lee-Anne Stayner, John Frederick Hilton, Daniel John Renouf, Trisha Denny, Graham Fletcher, Tak W Mak, Mark R Bray, Philippe L Bedard

Institutions: Princess Margaret Cancer Centre, Ottawa Hospital, BC Cancer Agency

Language: English

Topic: Microtubule and mitosis dynamics

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2758553293

Cites:

Cited by: 4

Related to: 10